In vivo inhibition of Bruton Tyrosine Kinase (BTK) protects against alcoholic liver disease
Prashanth Thevkar Nagesh(New York University), G. Szabó(Beth Israel Deaconess Medical Center), Mrigya Babuta(University of Hyderabad), Eleni Kanata(Max Planck Institute for Molecular Genetics), Michelle Lai(Beth Israel Deaconess Medical Center), Ioannis S. Vlachos(Broad Institute), Vilas Patwardhan(Beth Israel Deaconess Medical Center), Zachary Fricker(Beth Israel Deaconess Medical Center), Alan Bonder(Beth Israel Deaconess Medical Center), Courtney A. Copeland(Beth Israel Deaconess Medical Center), Y. Cho(Beth Israel Deaconess Medical Center), Matthew A. Curry(Beth Israel Deaconess Medical Center), Zhiqiang Jiang, Ruchira Joshi(Beth Israel Deaconess Medical Center), J. Lee(Beth Israel Deaconess Medical Center), A.R. Amigo(Beth Israel Deaconess Medical Center)
Cited by 0
Related Papers
DIANA-miRPath v3.0: deciphering microRNA function with experimental support
|Nucleic Acids Research|2015|1.8k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions
|Nucleic Acids Research|2017|1.2k
DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
|Nucleic Acids Research|2013|1.2k
DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions
|Nucleic Acids Research|2014|815